This federal contract award is for the purchase of QUICKVUE AT-HOME COVID-19 TESTS by the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,527.78, is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation.
The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide. Amerisourcebergen also holds another notable IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and pharmaceutical items.
By leveraging its extensive supply chain network, Amerisourcebergen has been awarded numerous federal contracts to supply critical care materials, such as COVID-19 tests, as well as a diverse range of medications to various defense and civilian agencies. These contract awards enable the U.S. government to efficiently procure essential pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries across different locations and healthcare settings.
Generated 11/15/24, 9:11 AM